Skip to content
Review

Calcium dysregulation in neurovascular function in Alzheimer's disease: mechanisms, therapeutic targets.

Aug 2026 · GeroScience · 0 citations · 143 references
Medicine

TL;DR

A systematic review of physiological Ca2+ handling mediated by plasma membrane channels, transporters, and intracellular organelles in the cerebral vasculature emphasizes Ca2+ signaling as a promising therapeutic target to break the vicious cycle of neurovascular impairment and neurodegeneration in AD.

View source

Similar papers

Review Open access Sep 2026

Brain endothelial homeostasis in psychiatric disorders: mechanisms, evidence, and translational opportunities

Brain endothelial cells (BECs) are specialized components of the neurovascular unit that couple circulating signals to cerebral blood flow regulation, blood–brain barrier (BBB) function, and selective molecular transport. This narrative review evaluates the correlation of these endothelial functions with psychiatric...

Meng-Jie Zhang, Xue-Ying Huang, Lin Yao et al. · 0 citations
Review Open access Aug 2026

Brain insulin resistance as a driver of proteinopathy in neurodegeneration: from cell-type-specific mechanisms to targeted therapeutics

Neurodegenerative diseases are increasingly linked to systemic metabolic dysfunction, with brain insulin resistance (BIR) positioned as a central mediator. Yet translating this insight into effective therapies has proven remarkably difficult. This review argues that BIR-driven neurodegeneration should be interpreted at...

Man Xiang, Si-Yu Cao, Xue-Heng Sun et al. · 0 citations
Review Open access Aug 2026

Astrocyte–blood–brain barrier crosstalk in cerebral small vessel disease: linking barrier dysfunction to neurovascular failure

Cerebral small vessel disease (CSVD) is a heterogeneous group of disorders involving the cerebral microvasculature and is a major cause of stroke and vascular cognitive impairment. The role of blood–brain barrier (BBB) dysfunction in CSVD is now recognized as a key pathological process; however, conventional vascular r...

Mei Xie, Shuang Wu, Ling Yang et al. · 0 citations
Review Open access Sep 2026

Blood–brain barrier dysfunction and peripheral immune activation in Alzheimer’s disease: an inflammation-centered review

An inflammation-centered model is proposed in which BBB breakdown and peripheral immune dysregulation form a pathogenic loop that accelerates neurodegeneration, and targeting this BBB–peripheral immune axis may provide new opportunities for biomarker development, patient stratification, and combination therapy beyond c...

Zu-Li Yang, Zhi-Qiang Xiao, Bin Huang et al. · 0 citations
Review Sep 2026

Crosstalk and Convergence in Alzheimer's Disease: Integrating Brain Injury, Neuroinflammation, and Precision Medicine for Next-Generation Therapeutics.

Alzheimer's Disease (AD) is a complex disorder whose underlying biology is not fully explained by traditional single-pathway models. For several decades, research has largely focused on the roles of amyloid-β and tau in the formation and deposition of plaques and neurofibrillary tangles associated with AD pathology and...

Desh Deepak Singh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.